Who Uses Claidex

Read by the researchers
running the next trial.

Claidex publishes mechanistic post-mortems on terminated drug programs. Researchers use them to understand what has already failed before committing to the same mechanism.

our impact

The record is growing. So is the signal.

Since launch, Claidex has documented failed programs across oncology, neurology, and immunology — tracing each one back to its preclinical roots.

TERMINATED TRIALS COVERED ACROSS DISEASE AREAS

0

UNIQUE MECHANISMS ANALYZED

0

AVERAGE DAYS FROM TERMINATION TO PUBLISHED CLAIM

0 days

Real Trials. Real Data.

Every hypothesis has a paper trail.

Each Claim traces the preclinical evidence that justified a trial, then follows it to where the chain broke. Nothing is invented. Every number is sourced.

Real Trials. Real Data.

Every hypothesis has a paper trail.

Each Claim traces the preclinical evidence that justified a trial, then follows it to where the chain broke. Nothing is invented. Every number is sourced.

Real Trials. Real Data.

Every hypothesis has a paper trail.

Each Claim traces the preclinical evidence that justified a trial, then follows it to where the chain broke. Nothing is invented. Every number is sourced.

Real Trials. Real Data.

Every hypothesis has a paper trail.

Each Claim traces the preclinical evidence that justified a trial, then follows it to where the chain broke. Nothing is invented. Every number is sourced.

Real Trials. Real Data.

Every hypothesis has a paper trail.

Each Claim traces the preclinical evidence that justified a trial, then follows it to where the chain broke. Nothing is invented. Every number is sourced.

READ AT LEADING ACADEMIC MEDICAL CENTERS

Where researchers found the record.

End to End Automation No Workflows needed